Effect of Octreotide on Saliva

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

September 24, 2019

Primary Completion Date

February 26, 2020

Study Completion Date

February 26, 2020

Conditions
Healthy
Interventions
DRUG

Octreotide 1 MG/ML

100 mcg (1 ml) of Octreotide

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duke University

OTHER